Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy.
Saved in:
| Title: | Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy. |
|---|---|
| Authors: | Cui, Hao1,2 (AUTHOR), Shu, Songren1,3 (AUTHOR), Zhang, Ningning1 (AUTHOR), Wang, Mangyuan1 (AUTHOR), Yang, Tianshuo1 (AUTHOR), Wang, Zhen1 (AUTHOR), Chen, Xiao1,2 (AUTHOR), Fu, Mengxia1,4 (AUTHOR), Xu, Mengda1,3 (AUTHOR), Yang, Yicheng1,5 (AUTHOR), Wang, Peizhi1,6,7 (AUTHOR), Wang, Chuangshi8 (AUTHOR), Yang, Qiaoxi1 (AUTHOR), Gao, Huimin1 (AUTHOR), Jiang, Yao1 (AUTHOR), Song, Jiangping1,2,3,9,10 (AUTHOR) fwsongjiangping@126.com |
| Source: | BMC Medicine. 4/14/2025, Vol. 23 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
